Biodesix Inc. (BDSX): Price and Financial Metrics

Biodesix Inc. (BDSX): $1.30

0.40 (-23.53%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add BDSX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#206 of 328

in industry

BDSX Price/Volume Stats

Current price $1.30 52-week high $2.21
Prev. close $1.70 52-week low $1.15
Day low $1.28 Volume 556,000
Day high $1.67 Avg. volume 149,753
50-day MA $1.72 Dividend yield N/A
200-day MA $1.60 Market Cap 188.73M

BDSX Stock Price Chart Interactive Chart >


Biodesix Inc. (BDSX) Company Bio


Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.


BDSX Latest News Stream


Event/Time News Detail
Loading, please wait...

BDSX Latest Social Stream


Loading social stream, please wait...

View Full BDSX Social Stream

BDSX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!